We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Breast Ultrasound Volume Calculator Accurately Monitors Cancer Treatment

By MedImaging International staff writers
Posted on 26 Sep 2022
Print article
Image: QTscan delivers safe, accurate monitoring of breast cancer treatment (Photo courtesy of QT Imaging)
Image: QTscan delivers safe, accurate monitoring of breast cancer treatment (Photo courtesy of QT Imaging)

Conventional breast imaging modalities, such as mammography, face tremendous challenges when imaging dense breast tissue, which puts women with dense breasts – nearly half the female population – at an immediate disadvantage. This is because cancer can appear similar to regular breast tissue and if there is a lot of breast tissue (such as in the case of dense breasts), the cancer can ‘hide’. Now, a new technology with the ability to image through dense breasts calculates the fibroglandular volume (FGV) of the breast and the ratio of FGV to total breast volume (TGV). This ratio can contribute to an assessment of risk for breast cancer and changes in this ratio can be used to measure the efficacy of medication used to treat or prevent breast cancer.

Unlike traditional breast imaging modalities, the QTscan from QT Imaging, Inc. (Novato, CA, USA) does not require radiation, injection, or compression, and is highly accurate (+ 0.2%), allowing earlier and more frequent monitoring for women undergoing non-surgical breast cancer treatments such as adjuvant chemotherapy, radiation therapy, cryotherapy, and hormone or selective hormone receptor modulation treatments. The U.S. Food and Drug Administration (FDA) has granted QT Imaging 510(K) clearance to calculate the FGV of the breast and the ratio of FGV to TGV. No other ultrasound-based breast imaging modality is cleared by the FDA to quantify fibroglandular volume.

The proposed indications for use, as designated by the FDA as breakthrough, are:

"The QT Scanner 2000 Model A is for use as an ultrasonic imaging system to provide reflection-mode and transmission-mode images of a patient's breast. The QT Scanner 2000 Model A software also calculates the breast fibroglandular tissue volume (FGV) value and the ratio of FGV to total breast volume (TBV) value as determined from reflection-mode and transmission-mode ultrasound images of a patient's breast. The device is not intended to be used as a replacement for screening mammography."

"The ability to determine a therapeutic clinical response using a quantitative volumetric method is crucial for effective and timely treatment of breast cancer and for patients at high risk for developing breast cancer who are receiving hormonal therapy. The FGV tool will allow this assessment to be made early and in follow-up to maximize treatment benefit, which is an exciting development for breast care patients," said Dr. Elaine Iuanow, a Breast Imaging specialist and medical consultant for QT Imaging.

"We are excited to expand the tools available using low frequency transmitted ultrasound volography to serve women, especially those with dense breasts, providing an imaging option that is safe, comfortable, and effective," said Dr. John Klock, CEO, Chief Medical Officer and Founder of QT Imaging, Inc.

Related Links:
QT Imaging, Inc. 

New
Gold Supplier
Portable X-Ray System
FDR Xair
New
X-Ray Wall Stand
PROVERT
New
CT Injector Syringe
MDT CT Injector Syringe
New
Ophthalmological AB Mode Ultrasound Scanner
ODU5

Print article
Sun Nuclear -    Mirion
FIME - Informa

Channels

Radiography

view channel
Image: BiOI ruby-like crystals can improve medical imaging safety by lowering intensities of harmful X-rays (Photo courtesy of University of Cambridge)

Sustainable Solar Cell Material Could Revolutionize Medical Imaging

The use of X-rays for internal body imaging has dramatically changed non-invasive medical diagnostics. Yet, the high dose of X-rays required for these imaging techniques, due to the poor performance of... Read more

MRI

view channel
Image: The AI-powered platform offers a game-changing solution for age-related disease detection and management (Photo courtesy of Freepik)

AI-Driven Imaging Platform Analyzes MRI Data for Early Detection of Age-Related Diseases

The increasing prevalence of age-related illnesses and their effects on patients, healthcare systems, and economies present a substantial challenge in the healthcare sector. As the global population ages,... Read more

Nuclear Medicine

view channel
Image: The components of the dosimeter can fit into an 18mm by 7mm capsule (Photo courtesy of University of NUS)

Novel Ingestible Capsule X-Ray Dosimeter Enables Real-Time Radiotherapy Monitoring

Gastric cancer ranks among the most prevalent cancers worldwide. Precision is vital in modern radiotherapy, as it aims to target tumor cells while minimizing damage to healthy tissue. However, challenges... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The global AI-enabled medical imaging solutions market is expected to reach USD 18.36 billion in 2032 (Photo courtesy of Freepik)

Global AI-Enabled Medical Imaging Solutions Market Driven by Need for Early Disease Detection

The AI-enabled medical imaging solutions market is currently in its developmental stages, following the significant role of AI-based tools in combating the COVID-19 pandemic. The pandemic saw an upswing... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.